Homocysteine and age-associated disorders

EA Ostrakhovitch, S Tabibzadeh - Ageing research reviews, 2019 - Elsevier
There are numerous theories of aging, a process which still seems inevitable. Aging leads to
cancer and multi-systemic disorders as well as chronic diseases. Decline in age-associated …

Wnt/β-catenin signalling and podocyte dysfunction in proteinuric kidney disease

L Zhou, Y Liu - Nature Reviews Nephrology, 2015 - nature.com
Podocytes are unique, highly specialized, terminally differentiated cells that are integral
components of the kidney glomerular filtration barrier. Podocytes are vulnerable to a variety …

Nod-like receptor protein 3 (NLRP3) inflammasome activation and podocyte injury via thioredoxin-interacting protein (TXNIP) during hyperhomocysteinemia

JM Abais, M Xia, G Li, Y Chen, SM Conley… - Journal of Biological …, 2014 - ASBMB
NADPH oxidase-derived reactive oxygen species (ROS) have been reported to activate
NLRP3 inflammasomes resulting in podocyte and glomerular injury during …

Role of NADPH oxidase‐mediated reactive oxygen species in podocyte injury

S Chen, XF Meng, C Zhang - BioMed research international, 2013 - Wiley Online Library
Proteinuria is an independent risk factor for end‐stage renal disease (ESRD)(Shankland,
2006). Recent studies highlighted the mechanisms of podocyte injury and implications for …

[HTML][HTML] Activation of inflammasomes in podocyte injury of mice on the high fat diet: effects of ASC gene deletion and silencing

KM Boini, M Xia, JM Abais, G Li, AL Pitzer… - … et Biophysica Acta (BBA …, 2014 - Elsevier
Inflammasome, an intracellular inflammatory machinery, has been reported to be involved in
a variety of chronic degenerative diseases such as atherosclerosis, autoinflammatory …

Contribution of endogenously produced reactive oxygen species to the activation of podocyte NLRP3 inflammasomes in hyperhomocysteinemia

JM Abais, M Xia, G Li, TWB Gehr, KM Boini… - Free Radical Biology and …, 2014 - Elsevier
Hyperhomocysteinemia (hHcys) is an important pathogenic factor contributing to the
progression of end-stage renal disease. Recent studies have demonstrated the implication …

Protective effects of acarbose against vascular endothelial dysfunction through inhibiting Nox4/NLRP3 inflammasome pathway in diabetic rats

XX Li, SK Ling, MY Hu, Y Ma, Y Li, PL Huang - Free Radical Biology and …, 2019 - Elsevier
The cardiovascular efficacy of glucose-lowering drugs is needed due to the cardiovascular
complication in type 2 diabetes mellitus (T2DM). Acarbose is an α-glucosidase inhibitor that …

Homocysteine in chronic kidney disease

EA Ostrakhovitch, S Tabibzadeh - Advances in clinical chemistry, 2015 - Elsevier
Hyperhomocysteinemia occurs in chronic-and end-stage kidney disease at the time when
dialysis or transplant becomes indispensable for survival. Excessive accumulation of …

Control of lysosomal TRPML1 channel activity and exosome release by acid ceramidase in mouse podocytes

G Li, D Huang, J Hong, OM Bhat… - American Journal of …, 2019 - journals.physiology.org
The transient receptor potential mucolipin 1 (TRPML1) channel has been reported to
mediate lysosomal Ca2+ release that is involved in Ca2+-dependent lysosome trafficking …

Role of NADPH oxidase in metabolic disease‐related renal injury: An update

C Wan, H Su, C Zhang - Oxidative medicine and cellular …, 2016 - Wiley Online Library
Metabolic syndrome has been linked to an increased risk of chronic kidney disease. The
underlying pathogenesis of metabolic disease‐related renal injury remains obscure …